[National survey of Advanced Practice Nurses in oncology-haematology: Evaluation of activity and continuing education].

Enquête nationale auprès des infirmiers en pratique avancée mention oncologie-hématologie : évaluation de l’activité et de la formation continue.
Advanced practice nurse Formation Hematology Hématologie Infirmier en pratique avancée Oncologie Oncology Training

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
13 Mar 2024
Historique:
received: 02 11 2023
revised: 05 12 2023
accepted: 07 12 2023
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 14 3 2024
Statut: aheadofprint

Résumé

The number of Advanced Practice Nurses (APNs) has significantly increased in France since 2019, with the number of graduates expected to reach 1700 by the end of 2023, up from approximately 60. Fifteen percent of them specialize in oncology-hematology (APN-OH). Data on their activities, access to continuing education, and expectations are limited. We conducted an observational study among practicing APN-OHs in France. A questionnaire was distributed from June to September 2023. Of the 55 responding APN-OHs, 78.3% worked in Cancer Centers or within University Hospital Centers. Their primary motivation for becoming APN-OH was to enhance their nursing practice and deepen their medical knowledge, with teaching and research interests remaining marginal. Their level of responsibility generally aligned with their expectations and the medical staff was perceived as supportive. The main challenges were of logistical and material nature. The heterogeneity in APN-OH training was seen as a limiting factor in the attractiveness of the profession. The most significant gaps in their education revolved around the lack of practical cases. This study highlights that the primary concern of APN-OHs is to strengthen their practical training. Medical personnel are perceived as supportive, but challenges related to working conditions and education persist. It is essential to consider these factors to support the deployment of APN-OHs across the country and improve ongoing education.

Identifiants

pubmed: 38485628
pii: S0007-4551(24)00050-X
doi: 10.1016/j.bulcan.2023.12.015
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Elvire Pons-Tostivint (E)

Medical Oncology, Nantes University, Centre Hospitalier Universitaire de Nantes, 44000 Nantes, France. Electronic address: elvire.pons@chu-nantes.fr.

Laure De Decker (L)

EA 1156-12, pôle hospitalo-universitaire de gérontologie clinique, département de gériatrie, UCOG Pays de la Loire, CHU de Nantes, Nantes, France.

Gaëlle Haudebert (G)

Nantes University, Centre Hospitalier Universitaire de Nantes, Nantes, France.

Pauline Hulo (P)

Medical Oncology, Nantes University, Centre Hospitalier Universitaire de Nantes, 44000 Nantes, France.

Jeanne Chen (J)

Medical Oncology, Nantes University, Centre Hospitalier Universitaire de Nantes, 44000 Nantes, France.

Jaafar Bennouna (J)

Department of Medical Oncology, Hôpital Foch, Suresnes, France.

Thierry Mira (T)

Département des études paramédicales, faculté de médecine, université Côte-d'Azur, 28, avenue de Valombrose, 06107 Nice, France.

Classifications MeSH